Клинико-иммунологические проявления первичного и вторичного антифосфолипидного синдрома
https://doi.org/10.14412/1995-4484-2004-796
Аннотация
Об авторах
T M ReshetnvakT N Kotelnikova
L A Kalashnikova
Т. А. Лисицына
E N Alexandrova
E S Mach
T L Tihonova
Земфира Садуллаевна Алекберова
V A Nassonova
А. В. Волков
V A Nassonova
E L Nassonov
Список литературы
1. <div><p>Wilson W.A., Gharavi А.Е., Koike Т. et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthr. Rheum. 1999, 42. 1309-1311</p><p>Asherson R.A. A "primary" antiphospopholipid syndrome? J. Rheumatol., 1988. 15. 1742-1746</p><p>Asherson R.A. Khamashta M.A., Ordi-Ros J. et al. The "primary” antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore), 1989, 68, 366374</p><p>Насонов Е.Л., Баранов А.А., Шилкина Н.П., Алекберова З.С. Патология сосудов при антифосфолнпидном синдроме (клиника, диагностика, лечение). М.-Ярославль, 1995, 161 стр.</p><p>Cervera R., Piette J.C., Font J. et al. Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthr. Rheum., 2002, 46, 1019-1027</p><p>Насонов Е.Л. Антифосфолипидный синдром. М., "Литтера”, 2004,379стр.</p><p>Font J., Lopez-Soto A. Cervera R. et al. The "primary" antiphospholipid syndrome: antiphospholipid antibody pat tern and clinical features of scries of 23 patients. Autoimmunity, 1991, 9, 69-75</p><p>Vianna I.L., Khamashta M.A., Ordi-Ros J. et al. Comparision of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients. AmJ.Med. 1994, 96, 3-9</p><p>Piette J.C. Wechsler B., Frances C. et al. Exclusion criteria for primary antiphospholipid syndrome. J.Rheumatol. 1993, 20, 1802-1804</p><p>Piette J.C., Wechsler B., Frances C., Godeau P. Systemic lupus erythematosus and antiphosphoplipid syndrome: reflection about the relevance of ARA criteria. J.Rheumatol., 1992, 19, 215-222</p><p>Hochberg M.C. Updating the American College of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthr. Rheum., 1997, 40, 1725</p><p>Tan E.M., Cohen A.S., Fries J.S. The 1982 revised criteria for the classification of svstemic lupus ervtheniatosus. Arth Rheum. 1982, 25, 1271-1277</p><p>Александрова E.H., Насонов Е.Л. Ковалев В.Ю. Количественный иммуноферментный метод определения антител к кардиолипину в сыворотке крови. Клин, реиматол. 1995, 4, 35-39</p><p>Bacharach J.M. Lie J.T. Homburger Н.А. The prevalence of vascular occlusive disease associated with antiphospholipid syndromes. Int.Angiol., 1992, II, 51-56 15,</p><p>Salafia C.M., Starzyk K., Lopez-Zeno J., Parke A. Fetal losses and other obstetric manifestations in the antiphospholipid syndrome. In 'The antiphospholipid syndrome” edited by Asherson R.A., Cervera R., Piette J,C., Shoenfeld Y. PRC Press Boca Raton New York London Tokyo, 1996, 117-131 16,</p><p>Garcia-ToiTes R., Amigo M-С., de la Rosa A. et al. Valvular heart disease in primary antiphospholipid syndrome (PAPS): clinical and morphological findings. Lupus, 1996, 5, 56-61</p><p>Nihoyannopoulos P., Gomez P.M., Joshi J. et al. Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies. Circulation, 1990, 82, 369-375</p><p>Asherson R.A., Hughes G.R.V. The expanding spectrum of Libman Sacks endocarditis: the role of antiphospholipid antibodies. Clin. Exp. Rheumatol., 1989, 7, 225-228</p><p>Brenner B. Blimenfeld Z., Markiewicz W., Reistier S.A. Cardiac involvement in patients with primary antiphospholipid syndrome.J.Am.Coll.Cardiol., 1991, 18, 931-936</p><p>Averback P. Primary cerebral venous thrombosis in yong adults: the diverse manifeststions of an unrecognized disease. Ann,Neurol., 1978, 3, 81-86</p><p>Levine S.R., Kieran S., Pusio K. et al. Cerebral venous sinus thrombosis with lupus anticoagulants: report: report of two cases. Stroke, 1987, 18, 801-803</p><p>Lau S.М., Bock G.H., Edson J.R., Michael A.T. Sagittal sinus thrombosis in nephrotic syndrome. J.Pediatr., 1980,97. 948-950</p><p>Brey R., Escalante A. Futrell N., Asherson R.A. Cerebral thrombosis and other neurological manifestation in the antiphospholipid syndrome. In "The antiphospholipid syndrome" edited by Asherson R.A., Cervera R. Piette J.C., Shoenfeld Y. PRC Press Boca Raton New York London - Tokyo. 1996, 3-13</p><p>Bouchez B. Arnott G., Hatron P. V. Choree et lupus ery- themateux dissemine avec anticoagulant circulnnt. Trois. Cas. Rev.Neurol. (Paris), 1985, 141, 571-577</p><p>Asherson R.A., Derksen E.H.W.N., Harris E.N. et al. Choreae in systemic lupus erthematosus and "lupus-like" disease. Association with antiphospholipid antibodies. Sem.Arthr. Rheum., 1987. 16. 253-259</p><p>Asherson R.A., Hughes G.R.V Antiphospholipid antibodies in chorea. J.Rheumatol., 1988, 15, 377-379</p><p>Brey R. Escalante A., Futrell N., Asherson R.A. Cerebral thrombosis and other neurological manifestation in the antiphospholipid syndrome. In "The antiphospholipid syndrome" edited by Asherson R.A., Cervera R., Piette J.C., Shoenfeld Y. PRC Press Boca Raton New York London - Tokyo. 1996, 3-13</p><p>Barber P.V., Arnold A.G., Evans G. Recurrent hormone dependent chorea: effects of prostogens. Clin.Endocrinol., 1976, 5, 291-293</p><p>Калашникова Л.А. Неврология антифосфолипидного синдрома. М. Медицина. 2003, 254</p><p>McHugh M.J,, Maymo J., Skinner R.P. et al. Anti- cardiolipin antibodies, livedo reticularis, and major cerebrovascular and renal disease in systemic lupus erythematosus. Ann.Rheum.Dts. 1988, 47, 110-115</p><p>Englert H.J., Loizou S., Derue G.G.M., Walport M.J., Hughes G.R.V. Clinical and immunollogic features of livedo reticularis in lupus: a case-control studv.Am.J.Med. 1989, 87, 408-410</p><p>Kalashnicova L.A., Nassonov E.L. Borisenko V.V., et al. Sneddon's syndromexariac pathology and antiphospholipid antibodies. Clin.Exp.Rheumatol., 1991, 9, 357-361</p><p>Alegre V.A., Gastineau D.A., Winkelmann R.K. Skin lesions associated with circulating lupus anticoagulant, Br.J.Dermatol., 1989, 120, 419-429</p><p>Becker J.C., Winkler B., Klingert S., Brocker E.B. Antiphospholipid syndrome associated with immunotherapy for patients with melanoma. Cancer, 1994, 73, 1621-1624</p><p>Stepansson E.A., Niemi K.M., Jouhikainen T. et al. Lupus anticoagulant and the skin. Along term follow-up study of SLE patients with special refernce of histopathological findings. Acta. Derm,Venerol.(Stokh.), 1991, 71, 416-422</p><p>Disdier P., Harle J.R., Andrac L. et al. Primary anetoderma with the antiphospholipid syndrome. J.Am.Acad.Dermatol., 1994, 30, 133-134</p></div><br />
Рецензия
Для цитирования:
Reshetnvak T.M., Kotelnikova T.N., Kalashnikova L.A., Лисицына Т.А., Alexandrova E.N., Mach E.S., Tihonova T.L., Алекберова З.С., Nassonova V.A., Волков А.В., Nassonova V.A., Nassonov E.L. Клинико-иммунологические проявления первичного и вторичного антифосфолипидного синдрома. Научно-практическая ревматология. 2004;42(4):15-23. https://doi.org/10.14412/1995-4484-2004-796
For citation:
Reshetnvak T.M., Kotelnikova T.N., Kalashnikova L.A., Lisitsyna T.A., Alexandrova E.N., Mach E.S., Tihonova T.L., Alekberova Z.S., Nassonova V.A., Volkov A.V., Nassonova V.A., Nassonov E.L. Clinical and immunological features of primary and secondary antiphospholipid syndrome. Rheumatology Science and Practice. 2004;42(4):15-23. (In Russ.) https://doi.org/10.14412/1995-4484-2004-796